XGN
EXAGEN INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$8.41
+6.86%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- $18.3M
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$0.13
- EPS estimate
- -$0.19
- Revenue actual
- $19.9M
- Revenue estimate
- $17.8M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +2.4%
- Revenue beats (12Q)
- 10
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $9.75
- PT range
- $8.00 – $12
- Analysts
- 4
4 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$0.19 | -$0.13 | Beat 32.09% | $19.9M |
| May 11, 2026 | -$0.24 | -$0.17 | Beat 29.17% | $17.3M |
| Mar 10, 2026 | -$0.19 | -$0.20 | Miss -5.43% | $16.6M |
| Nov 4, 2025 | -$0.13 | -$0.19 | Miss -46.15% | $17.2M |
| Mar 11, 2025 | -$0.27 | -$0.20 | Beat 25.93% | $13.7M |
| Mar 18, 2024 | -$0.41 | -$0.31 | Beat 24.39% | $13.8M |
| Nov 13, 2023 | -$0.50 | -$0.31 | Beat 38.00% | $13.4M |
| May 15, 2023 | -$0.52 | -$0.44 | Beat 15.38% | $11.2M |
| Mar 20, 2023 | -$0.71 | -$0.58 | Beat 18.31% | $12.8M |
| Nov 14, 2022 | -$0.76 | -$0.47 | Beat 38.16% | $14.7M |
| Aug 4, 2022 | -$0.55 | -$0.78 | Miss -41.82% | $9.0M |
| Mar 22, 2022 | -$0.49 | -$0.42 | Beat 14.29% | $12.7M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026